Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
42 employees
Faro Health: Streamlining clinical trials with our cloud-native platform.
HQ
Founded
2019
Faro Health was founded with the mission to streamline and revolutionize the clinical trial process through advanced technology. The company's core vision is to enhance the efficiency and accuracy of clinical trials by leveraging a cloud-native platform. Faro Health offers solutions such as Protocol Design, AI Co-Pilot, and Downstream System Integration & Digital Data Flow, focusing on reducing the manual workload and improving data management in clinical trials. Their market focus is primarily on pharmaceutical companies and research organizations seeking to optimize clinical trial operations.
Notable affiliates of Faro Health include experienced professionals in the fields of clinical research and technology. The company has garnered attention from investors interested in healthcare innovation. Key achievements include the successful implementation of their platform in numerous clinical trials, leading to significant improvements in trial efficiency and data integrity. Faro Health's impact lies in its ability to accelerate the clinical trial process, ultimately contributing to faster development of medical treatments and therapies.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Clinical Trials Software
Technology
AI, Cloud
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Faro Health founded?
Faro Health was founded in 2019.
Where is Faro Health's headquarters located?
Faro Health's headquarters is located in San Diego, CA, US.
When was Faro Health's last funding round?
Faro Health's most recent funding round was for $20M (USD) in February 2023.
How many employees does Faro Health have?
Faro Health has 42 employees as of Feb 4, 2024.
How much has Faro Health raised to-date?
As of July 05, 2023, Faro Health has raised a total of $35M (USD) since Feb 8, 2023.
Add Comparison
Total Raised to Date
$35M
USD
Last Update Feb 8, 2023
Last Deal Details
$20M
USD
Feb 8, 2023
Series A
Current Employees
42
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts